Hi Jill,
Could you send me the R numbers for the participant Bhagat-Taaj Sian and
David Wafer please?
Thank you!
Florence
--
*Florence Ruby *
*PhD Student *
*Department of Psychology*
*University of York, *
*Heslington, York, YO10 5DD, UK *
*Phone: 0044 (0) 190 432 4648*
*Email: fjmr500(a)york.ac.uk <fjmr500(a)york.ac.uk>*
*PostDoc in Neuroimaging (scholarship)*
*Karolinska Institutet, Institutionen för neurovetenskap, Ehrsson*
We are seeking a highly talented, innovative and enthusiastic researcher
with a PhD in neuroimaging awarded within the past three years to work
on projects in which advanced functional magnetic resonance imaging
(fMRI) analysis methods are applied to the problem of how we
perceive our own body in space.
The research will be conducted at the Brain, Body and Self Laboratory at
the Department of Neuroscience (www.ehrssonlab.se
<http://www.ehrssonlab.se>). This center has widespread expertise in
fMRI, and the Karolinska Institutet has two MR-centers with
state-of-the-art 3T MR scanners (GE and Siemens, respectively).
The ideal candidate will have expertise in the acquisition and analysis
of fMRI data, as well as excellent programming skills. Expertise in
multivariate pattern recognition, voxel-based receptive field mapping,
would be an advantage, as would an undergraduate education in
engineering (or a related area). The candidate is expected to work on
projects in which advanced fMRI methods are applied to questions
relating to how multisensory signals from the body are integrated at the
levels of cortical and subcortical structures and/or the decoding of
body illusions; however, purely technical projects involving
method development are also possible. Good social skills are important
as the candidate is expected to actively collaborate with other members
of the laboratory, in addition to running his or her own
project. Applicants should be able to demonstrate a consistently good
academic record, including publications in international journals.
The position is limited to an initial 12-month period with the
possibility of extension for an additional 12 months. For applicants
with a foreign PhD, the positions are funded by a scholarship.
For further information and details about the application process:
*https://ki.mynetworkglobal.com/en/what:job/jobID:40670/where:/*
*Last application date: 21.Aug.2014*
———
Henrik Ehrsson, M.D., Ph.D.
Professor
Karolinska Institutet
Department of Neuroscience
Brain, Body and Self Laboratory
Adress: Retzius väg 8, SE-17177 Stockholm, Sweden
Phone: +46-(0)852487231
Fax: +46-(0)852487126
Email: Henrik.Ehrsson(a)ki.se <mailto:Henrik.Ehrsson@ki.se>
Web: www.ehrssonlab.se <http://www.ehrssonlab.se>
Research Assistant / Associate Ref: M00563 Grade 6/7: £26,527 - £29,837
/ £32,590 - £36,661 per annum You will contribute to a project entitled
“Magnetoencephalography and Clinical Research in Schizophrenia”.
Specifically, the job requires the analysis and acquisition of MEG-data
sets and implementation of novel analytic tools, contributing to the
design and programming of MEG experiments, recruiting and running the
participants, assisting in analysing the results, and participating in
the writing up of the results. With extensive, up-to-date practical
knowledge in MEG or EEG, you will have excellent knowledge of
source-localization, Matlab and experimental control software. This post
is funded for 2 years Informal enquires to Dr Peter Uhlhaas (Email:
Peter.Uhlhaas(a)glasgow.ac.uk; Tel: 0141 330 8730) Apply online at:
www.gla.ac.uk/jobs Closing date: 11st of August 2014 The University has
recently been awarded the Athena SWAN Institutional Bronze Award The
University is committed to equality of opportunity in employment. The
University of Glasgow, charity number SC004401. Dr. Peter J. Uhlhaas
Reader Institute for Neuroscience and Psychology University of Glasgow
58 Hillhead Street Glasgow G12 8QB Telephone +44 (0)141 330 8730
A funded postdoctoral position is available in the lab of Adam Aron
(www.aronlab.org <http://www.aronlab.org>).
Projects are focused on motor inhibitory control and its relation to
attention, working memory, motivation/limbic-function and Parkinson’s
disease. The lab has diverse resources including EEG, ECoG, fMRI, TMS
and access to patients.
Candidates should hold a Ph.D (or be about to be awarded one) in any of
cognitive psychology, behavioral neuroscience or cognitive neuroscience.
Applications (consisting of a cover letter describing research interests
and how those are a match for the lab, a CV, and contact info for
references) should be sent to adamaron [@] ucsd.edu <http://ucsd.edu>.
Salary is commensurate with NIH-rates. Full University of California
benefits are provided.
Deadline for applications is August 15th 2014.
The duration of the position is for up to 3 years.
———————————————————
Adam R Aron, PhD
Associate Professor
Department of Psychology
Neuroscience Graduate Program
University of California, San Diego
web: www.aronlab.org <http://www.aronlab.org/>
See below for the Abstract for Don McLaren's talk. As a reminder he will be
talking in BO20 at 4pm on the 21st of July. Hope to see you all there.
Best,
Jonny
*The Potential of Functional MRI in Early Phase Clinical Trials: Looking
Forward*
With promising therapies for Alzheimer’s disease (AD) entering clinical
trials, functional magnetic resonance imaging (fMRI) has potential as a
biomarker of trait or state to identify individuals who may be at higher
risk or who are showing early neurophysiological changes in cognitive
networks, and as a biomarker of rate, effect or efficacy to provide an
early biological signal to prognosticate, gauge clinical progression or
treatment response. The majority of fMRI studies in patients with AD have
nevertheless focused on regional task-related activity rather than how
functional connectivity during performance of a cognitive task can be
related to disease stage, treatment or a clinical outcome measure. The use
of fMRI in clinical trials will require a network perspective of brain
activity and connectivity.
The utilization of fMRI in clinical trials requires: (1) a well-known
underlying pathology; (2) a well-validated reliable cognitive paradigm; and
(3) sensitive and reliable analysis methodology. Using Alzheimer’s disease
an exemplar, I will outline the pathological processes in Alzheimer’s
disease. I will describe several paradigms for probing episodic memory, the
hallmark symptom in Alzheimer’s disease. Finally, I will discuss different
fMRI analysis approaches and how to could be leveraged in clinical trials.
In particular, I will focus on using generalized psychophysiological
interactions (gPPI) to identify potential candidate networks for cognitive
and pharmacological interventions.
Nevertheless, it is important to recognize that fMRI will never be the sole
determinant in making decisions about to proceed or stop a clinical trial.
To that end, I will briefly present some novel ideas about improving
sensitivity of cognitive performance measures in longitudinal studies and
mention some recent findings in other imaging modalities. I will end with
some thoughts about how to integrate multiple modalities.
The goal of bringing imaging and other modalities into a clinical trial is
reduce the duration and number of subjects in the trial without
compromising the science. Ultimately, using fMRI as a complementary
approach in clinical trials will improve the throughput.
Hi YNIC users
One of my collaborators Don McClaren (http://www.martinos.org/~mclaren/) is
going to be at York on the 21st of July to give a talk. He has done a lot
of work on both fMRI methods, and their application to clinical disorders.
If you have ever posted questions on the SPM mailing list, there is a good
chance he has replied.
Don is going to talk about applying fMRI as a clinical tool (abstract to
follow). It will take place at 4pm in BO20.
Hope to see you there. There will be a dinner afterwards so let me know if
you want to be involved.
Jonny
